Find and Join

News Logo

• Tattoos, legal counsel, and good info

  If APC had a tattoo on its bicep — if we had a bicep, I mean — it might well read “Consult legal counsel.” read more →

• State advocacy update

  APC sent a letter to the New Mexico Board of Pharmacy this week commenting on its proposed amendments that would align the state with USP (good), but would also require that pharmacists ensure all flavors are inert (yikes). read more →

• Board approves new officer succession

  The APC Board of Directors has voted to name Gina Besteman (previously vice president) the board chair-elect after the resignation of Michelle Moser from the position. Besteman will assume the chair in January 2025. read more →

• FDA is concerned about compounded GLP-1 dosing errors

  Earlier this week APC received a letter from the FDA explaining the agency's concerns regarding dosing and patient usage of compounded semaglutide and tirzepatide. read more →

• Did you get your Compounding Pharmacy Snapshot?

  If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America. read more →

• After report, FTC to sue PBMs

  On Tuesday, the Federal Trade Commission released a scathing, two-years-in-the-making report about PBMs. read more →

More News

PCCA Ad

Blank

Medisca Ad

Blank

Fagron Ad

Blank

Wedgewood Ad

Blank

TopiClick Ad

Thanks to shepherding by APC and the National Alliance of State Pharmacy Associations, 40 state and national pharmacy associations have signed a joint letter (https://fllw.me/3DfHcVr) to congressmen Morgan Griffith and Henry Cuellar in support of HR3662, the bipartisan urgent-access and shortage drug bill that the two representatives are sponsoring.

A big thank-you to all our partners in the effort to pass this bill. We expect that Reps. Cuellar and Griffith will be able to use this letter to help encourage their colleagues to cosponsor the legislation.

You can help! Take five minutes to call or email your member of Congress and ask them to cosponsor HR3662, the “Patient Access to Urgent-Use Pharmacy Compounding Act,” to protect Americans’ access to critical medication! (And if your state pharmacy association is one that signed on to our letter, please thank them.)